Related Experiment Video
Updated: May 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Duration of antimicrobial therapy in cardiovascular implantable electronic device associated systemic infections: a
Emily Y Xiao1, Patrick T Lynch2, Sarwat Khalil3
1Baylor College of Medicine Department of Internal Medicine 7200 Cambridge Street, Houston, TX 77030, USA.
Insights
Shorter antibiotic durations after cardiovascular implantable electronic device removal are safe for treating infections. This study found no difference in mortality or recurrent bacteremia with shorter or longer antibiotic courses.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Device Infections
Background:
- Complete removal of cardiovascular implantable electronic devices (CIEDs) is crucial for infection treatment.
- Optimal antimicrobial therapy duration post-CIED removal remains unclear.
Purpose of the Study:
- To evaluate the impact of antimicrobial therapy duration on clinical outcomes in patients with CIED-associated bacteremia and lead endocarditis.
Main Methods:
- Retrospective cohort study of 79 patients undergoing CIED removal for infection.
- Patients were stratified into two groups based on antibiotic duration: ≤2 weeks or >2 weeks post-extraction.
- Outcomes included 90-day mortality, recurrent bacteremia, infectious complications, and hospital length of stay.
Main Results:
- No significant differences were observed in survival, recurrent bacteremia, infectious complications, or hospital length of stay between the short-term and long-term antibiotic groups.
- Mean antibiotic duration was 12.6 days for the ≤2 weeks group and 38.6 days for the >2 weeks group.
- Recurrent bacteremia occurred in 5 patients, primarily associated with high-risk organisms and underlying cardiac conditions.
Conclusions:
- Shorter antibiotic durations (≤2 weeks) following CIED removal are associated with similar clinical outcomes compared to longer durations.
- Recurrence of infection is linked to specific high-risk pathogens and patient comorbidities.
- Further prospective research is warranted to confirm these findings.
Background:
While the need for complete device removal is well-established for cardiovascular implantable electronic device (CIED) infections, there is insufficient evidence on the optimal duration of antimicrobial therapy.
Objectives:
To examine how antimicrobial duration affects clinical outcomes of patients presenting with CIED-associated bacteremia and lead endocarditis.
Design:
This is a retrospective cohort study conducted at a quaternary care hospital in Houston, TX, USA.
Methods:
Patients who underwent device removal for a primary indication of bacteremia or lead endocarditis over a 10-year period were stratified by prescribed duration of antibiotics as ⩽2 weeks or >2 weeks post-extraction. Measured outcomes included all-cause mortality at 90 days, recurrent bacteremia, infectious complications, and hospital length of stay.
Results:
Of 747 patients who underwent lead extraction at Baylor St. Luke's Medical Center between June 2013 and December 2023, 79 cases met the inclusion criteria. Baseline characteristics were similar between cohorts. Mean duration of antibiotics prescription was 12.6 versus 38.6 days. There was no observed difference in survival (HR 0.693, 95% CI 0.085-5.652, p = 0.438), recurrent bacteremia (7% vs 6%, p = 0.952), infectious complications (27% vs 30%, p = 0.817), and hospital length of stay (mean 9.9 vs 13.3, p = 0.360) between the ⩽2 weeks and >2 weeks cohort, respectively. Five patients had recurrence, all of whom had bacteremia from Staphylococcus aureus or Serratia sp. and an underlying left ventricular assist device or valve replacement.
Conclusion:
Shorter duration of antibiotics after complete CIED removal had similar rates of mortality or recurrent bacteremia. Recurrence was associated with bacteremia from high-risk organisms with potential for secondary seeding of other cardiovascular prostheses. Larger prospective studies are needed to explore these findings.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management

